Assessing Intranasal Drug Delivery for Acute Neurological Conditions

Time: 4:00 pm
day: Conference Day Two

Details:

  • Utilizing concussion as a model for targeted intranasal drug delivery in acute neuro conditions
  • Sharing PK data and more from Phase I trials ahead of Phase II, including CSF vs. Blood concentration
  • Understanding the potential of spray-dried, lightweight device products for easy, safe actuation on-field

Speakers: